CME Certificates will be issued digitally after Speaker Evaluations and Overall Surveys are completed. Surveys are accessible after logging in with the email address you submitted during registration. Surveys will be available online starting the day of the symposium. You must complete the process by August 7, 2023 in order to receive your certificate. Certificates will be available online until December 31st and are printable directly from the website.

If you have already registered for in-person or virtual attendance, login to access the Hybrid Event home page, Symposium Syllabus, Speaker Slides and CME Surveys (valid registration email address required).


The AAFP has reviewed 29th Annual San Diego Heart Failure Symposium and deemed it acceptable for up to 10.25 Live AAFP Prescribed credits. Term of Approval is from 07/14/2023 to 07/15/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.


New insights into the epidemiology, pathophysiology and treatment of heart failure are occurring rapidly. The primary objective of the 29th Annual San Diego Heart Failure Symposium is to provide the most up-to-date information about recent advances in heart failure and present them in the context of how they can be implemented in clinical practice. The Symposium is structured around a series of sessions that include didactic presentations, case presentations and panel discussions. Audience participation is encouraged. This year's Symposium will present sessions on Modifying Lifestyle and Treating Risk Factors, Hypertrophic Cardiomyopathy, HFpEF and Amyloid, Cardiac Arrythmias/Prevention of Sudden Death and Devices to Improve Cardiac Function, Medical Management of Heart Failure, Percutaneous Approaches for Supporting Cardiac Function, Managing Patients with End-Stage Heart Failure. These talks will present a comprehensive overview of new drugs, devices and strategies for treating patients with heart failure and will provide practical approaches for implementation. A highlight of the Symposium will be the 9th Annual Stanley Lloyd, M.D. Lecture. The outstanding faculty includes world renowned experts in heart failure and other related fields. At this year’s Symposium the audience will have the opportunity to listen to patient perspectives as we recognize that better understanding of how heart failure and its treatment is perceived in the community is vital for our ability to offer outstanding healthcare to our patients.

As in the past, the Symposium will be presented in hybrid format. We encourage providers to attend the live presentations at the beautiful Hilton La Jolla Torrey Pines where they can interact with their colleagues, speakers and industry representatives over the two day Symposium. For those who can’t attend, on-line streaming of all sessions will be available. In addition, the Symposium will be available on-line for several weeks so that you will be able to return to lectures of interest or catch up on those that you missed.


At the conclusion of this activity, participants should be able to:

  1. Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.
  2. Review strategies for implementing medical and device therapies that will lead to improved outcomes in heart failure patients.
  3. Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure.

The target audience for this activity includes cardiologists, internists, primary care physicians, nurses and allied healthcare professionals.


Heart failure (HF) is common, currently affecting well over million Americans. Moreover, prevalence is increasing in both developed and developing countries around the world. In the U.S. alone, an estimated 670,000 new cases of heart failure are diagnosed each year. Perhaps of greatest importance is that heart failure is a major cause of morbidity and mortality. Within 8 years of diagnosis, 80% of men and 70% of women less than 65 years of age with new onset heart failure will die. Overall, HF is the number one cause of hospitalizations of the elderly in the U.S.

Knowledge about HF is accumulating rapidly. The Symposium is designed to help clinicians synthesize new information about heart failure and integrate it into effective strategies of care of their patients. The Symposium will provide a comprehensive overview of diagnostic approaches, current evidence-based therapies and treatment strategies as well as emerging approaches for treatment.